No increased Ki67 expression in ductal carcinoma in situ associated with invasive breast cancer

被引：0
|
作者：
Hoque, A
Menter, DG
Sahin, AA
Sneige, N
Lippman, SM
机构：
[1] Univ Texas, MD Anderson Canc Ctr, Dept Clin Canc Prevent, Houston, TX 77030 USA
[2] Univ Texas, MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA
来源：
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION | 2001年 / 10卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：153 / 154
页数：2
相关论文
共 50 条
  • [21] Expression, assessment and significance of Ki67 expression in breast cancer: an update
    Lashen, Ayat Gamal
    Toss, Michael S.
    Ghannam, Suzan Fathy
    Makhlouf, Shorouk
    Green, Andrew
    Mongan, Nigel P.
    Rakha, Emad
    JOURNAL OF CLINICAL PATHOLOGY, 2023, 76 (06) : 357 - 364
  • [22] Prognostic value of Ki67 labelling index in invasive breast cancer
    Zabieglinski, T.
    Kunzmann, V
    Hass, H. G.
    ONKOLOGIE, 2013, 36 : 175 - 176
  • [23] Assessment of Ki67 in Breast Cancer: Recommendations from the International Ki67 in Breast Cancer Working Group
    Dowsett, Mitch
    Nielsen, Torsten O.
    A'Hern, Roger
    Bartlett, John
    Coombes, R. Charles
    Cuzick, Jack
    Ellis, Matthew
    Henry, N. Lynn
    Hugh, Judith C.
    Lively, Tracy
    McShane, Lisa
    Paik, Soon
    Penault-Llorca, Frederique
    Prudkin, Ljudmila
    Regan, Meredith
    Salter, Janine
    Sotiriou, Christos
    Smith, Ian E.
    Viale, Giuseppe
    Zujewski, Jo Anne
    Hayes, Daniel F.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2011, 103 (22): : 1656 - 1664
  • [24] Gene expression profiling revealed MCM3 to be a better marker than Ki67 in prognosis of invasive ductal breast carcinoma patients
    Zhao, Yue
    Wang, Yimin
    Zhu, Fudi
    Zhang, Jiayu
    Ma, Xiao
    Zhang, Dongwei
    CLINICAL AND EXPERIMENTAL MEDICINE, 2020, 20 (02) : 249 - 259
  • [25] The expression of proliferating antigen Ki67 and PCNA and products of suppressor gene p53 in primary invasive ductal carcinoma of female breast
    Niewiadomska, H
    Jeziorski, A
    Mirowski, M
    Blonski, J
    EUROPEAN JOURNAL OF CANCER, 1998, 34 : S115 - S115
  • [26] Gene expression profiling revealed MCM3 to be a better marker than Ki67 in prognosis of invasive ductal breast carcinoma patients
    Yue Zhao
    Yimin Wang
    Fudi Zhu
    Jiayu Zhang
    Xiao Ma
    Dongwei Zhang
    Clinical and Experimental Medicine, 2020, 20 : 249 - 259
  • [27] Ki67 and Outcome in early Breast Carcinoma
    Danzinger, S.
    Pfeifer, C.
    Schirwani, N.
    Singer, F. C.
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2022, 82 (06) : S45 - S45
  • [28] Co-Expression of p16, Ki67 and COX-2 Is Associated with Basal Phenotype in High-Grade Ductal Carcinoma In Situ of the Breast
    Perez, Amanda Arantes
    Balabram, Debora
    Rocha, Rafael Malagoli
    Souza, Atila da Silva
    Gobbi, Helenice
    JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 2015, 63 (06) : 408 - 416
  • [29] Computerized image analysis of Ki-67 in ductal breast carcinoma in situ
    Menter, DG
    Hoque, A
    Motiwala, N
    Sahin, AA
    Sneige, N
    Lieberman, R
    Lippman, SM
    ANALYTICAL AND QUANTITATIVE CYTOLOGY AND HISTOLOGY, 2001, 23 (03): : 218 - 228
  • [30] Protein expression of TP53 and ki67 in some Nigerian triple negative invasive ductal breast cancers
    Obiorah, C.
    Nna, E.
    Madukwe, J.
    Sunday, I.
    HISTOPATHOLOGY, 2012, 61 : 26 - 26
12345